Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGeorgia Capital Regulatory News (CGEO)

Share Price Information for Georgia Capital (CGEO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 863.00
Bid: 860.00
Ask: 874.00
Change: 4.00 (0.47%)
Spread: 14.00 (1.628%)
Open: 862.00
High: 870.00
Low: 847.00
Prev. Close: 859.00
CGEO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Change in management at Georgia Healthcare Group

29 Jul 2022 15:06

RNS Number : 3143U
Georgia Capital PLC
29 July 2022
 

London, 29 July 2022

 

 

Georgia Capital announces that Nick Gamkrelidze is to step down as CEO of Georgia Healthcare

Georgia Capital PLC (the "Company" or "Georgia Capital") announces today that Nikoloz (Nick) Gamkrelidze is to step down as Chief Executive of JSC Georgia Healthcare Group ("GHG"), the wholly-owned subsidiary of Georgia Capital. He will be replaced as GHG's CEO by Irakli Gogia, currently Deputy CEO, Finance of GHG with immediate effect.

 

On 9 May 2022, the Board announced the separation of the roles of Georgia Capital's Chairman and CEO, upon the completion of Irakli Gilauri's current employment contract as Chairman and CEO in May 2023, with Irakli Gilauri continuing in the role of Board Chairman and Nick Gamkrelidze assuming the role of Chief Executive Officer in May 2023. Following Nick's departure from GHG, he will not now take up the role of Georgia Capital CEO in May 2023, and the Board of Georgia Capital will announce a further update in due course with regard to the appointment of a new CEO. Irakli Gilauri, as previously announced, will continue in his existing combined Chairman and CEO role until May 2023.

 

Irakli Gilauri, Chairman and CEO of Georgia Capital, commented: "Nick has been with the Group in a number of senior management positions for many years and has more recently been instrumental in the development of Georgia Healthcare over the last decade. He has created a great business that has delivered, and continues to do so, an excellent operational performance resulting in consistent strong growth and profitability. He has also been actively involved in Georgia's management of the global pandemic over the last 2 years, and he leaves with our strong gratitude for all of his outstanding achievements. Nick has also built and developed a fantastic management team, and it is great that we have Irakli Gogia in the position to succeed Nick with immediate effect."

 

Nick Gamkrelidze commented: "It has been my privilege to have led Georgia Healthcare through all of its successes over the last 7 years. The business is a great ongoing success story reflecting the significant progress the excellent management and clinical teams have made in institutionalising exceptional governance and high standards of clinical and operational performance. Going forward, the business could not be in better hands than those of Irakli Gogia, and I wish him and the entire team the very best success. I am certain they will continue to deliver exceptional performance."

 

Irakli Gogia commented: "It is a great honour and a privilege to take on the role of CEO of Georgia Healthcare Group. I would like to thank Nick for his invaluable contribution building the GHG healthcare institution, with a highly professional and capable management team, that creates substantial value for the country and for our shareholders."

 

 

 

 

 

Name of authorised official of issuer responsible for making notification: Michael Oliver, Adviser to the Chairman & CEO.

 

This announcement contains information that qualified or may have qualified as inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of the UK domestic law by virtue of the European Union (Withdrawal) Act 2018.

 

About Georgia Capital PLC

Georgia Capital is a platform for buying, building and developing businesses in Georgia with holdings in sectors that are expected to benefit from the continued growth and further diversification of the Georgian economy. The Group's focus is typically on larger-scale investment opportunities in Georgia, which have the potential to reach at least GEL 300 million equity value over 3-5 years from the initial investment and to monetise them through exits, as investments mature. Georgia Capital currently has the following portfolio businesses: (i) a healthcare services business; (ii) a retail (pharmacy) business, (iii) an insurance business (P&C and medical insurance); (iv) a renewable energy business (hydro and wind assets) and (v) an education business; Georgia Capital also holds other small private businesses across different industries in Georgia; a 20% equity stake in the water utility business and a 19.9% equity stake in LSE premium-listed Bank of Georgia Group PLC ("BoG"), a leading universal bank in Georgia.

JSC Georgia Capital has, as of the date hereof, the following credit ratings:

S&P Global

'B+'/FC & 'B+'/LC

Moody's

B1/CFR & B1/PDR

 For further information, please visit www.georgiacapital.ge or contact:

Irakli Gilauri

Giorgi Alpaidze

Michael Oliver

Shalva Bukia

Chairman and Chief Executive

Chief Financial Officer

Adviser to the Chairman & CEO

Head of Investor Relations

ir@gcap.ge

+995 322 005 000

+44 203 178 4034

+ 995 322 005 045

ir@gcap.ge

ir@gcap.ge

ir@gcap.ge


This news report is presented for general informational purposes only and should not be construed as an offer to sell or the solicitation of an offer to buy any securities

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGZGZNDLKGZZM
Date   Source Headline
3rd Sep 20209:04 amBUSForm 8.3 - Georgia Capital plc
2nd Sep 20201:27 pmRNSTotal Voting Rights
2nd Sep 20208:07 amRNSADMISSION OF ADDITIONAL SHARES IN GEORGIA CAPITAL
1st Sep 20209:14 amBUSForm 8.3 - Georgia Capital plc
1st Sep 20208:17 amRNSExpected admission of additional shares
25th Aug 20204:27 pmRNSDirector/PDMR Shareholding
20th Aug 20207:00 amRNSHalf-year Report
13th Aug 20207:00 amRNSNotice of Results
5th Aug 20209:08 amBUSForm 8.3 - Georgia Capital plc
5th Aug 20208:07 amRNSCancellation of listing of GHG PLC
3rd Aug 20204:24 pmRNSTotal Voting Rights
27th Jul 20204:32 pmRNSHolding(s) in Company
24th Jul 20209:54 amRNSGGU issues US$ 250 million green bonds
22nd Jul 20205:12 pmRNSTotal Voting Rights
22nd Jul 20208:13 amRNSAdmission of additional shares
21st Jul 20202:11 pmRNSExpected admission of additional shares
20th Jul 20208:39 amBUSForm 8.3 - Georgia Capital plc
17th Jul 202010:45 amBUSForm 8.3 - Georgia Capital plc
17th Jul 20208:00 amRNSClose of offer & compulsory purchase of GHG shares
15th Jul 20203:00 pmRNSDirector/PDMR Shareholding
15th Jul 20202:13 pmRNSDirector/PDMR Shareholding
14th Jul 20203:18 pmRNSDirector/PDMR Shareholding
13th Jul 20205:40 pmRNSDirector/PDMR Shareholding
13th Jul 20209:45 amRNSHolding(s) in Company
13th Jul 20208:45 amBUSForm 8.3 - Georgia Capital plc
10th Jul 20205:14 pmRNSDirector/PDMR Shareholding
10th Jul 202010:51 amRNSHolding(s) in Company
9th Jul 20209:55 amBUSForm 8.3 - Georgia Capital plc
8th Jul 20205:30 pmRNSGeorgia Capital
8th Jul 20204:00 pmRNSTotal Voting Rights
8th Jul 20209:33 amBUSForm 8.3 - Georgia Capital plc
8th Jul 20208:14 amRNSOffer declared unconditional in all respects
7th Jul 20202:37 pmRNSADMISSION OF SHARES IN GEORGIA CAPITAL PLC
7th Jul 202012:07 pmRNSSecond Price Monitoring Extn
7th Jul 202012:02 pmRNSPrice Monitoring Extension
6th Jul 202012:42 pmRNSResults of General Meeting
3rd Jul 20202:09 pmBUSForm 8.3 - Georgia Capital plc
3rd Jul 20201:45 pmRNSForm 8.3 - [Georgia Capital plc]
3rd Jul 20207:45 amGNWForm 8.5 (EPT/RI) - Georgia Capital plc
2nd Jul 20204:32 pmEQSForm 8.3 - The Vanguard Group, Inc.: Georgia Capital plc
2nd Jul 20203:27 pmRNSOffer unconditional as to acceptances
2nd Jul 20202:32 pmRNSForm 8.3 - [Georgia Capital plc]
2nd Jul 20202:16 pmRNSForm 8.3 - Georgia Capital plc
2nd Jul 20208:33 amRNSForm 8.5 (EPT/RI) - Georgia Capital plc
1st Jul 20209:00 amBUSForm 8.3 - Georgia Capital Plc
1st Jul 20208:43 amRNSForm 8.5 (EPT/RI) - Georgia Capital plc
30th Jun 202012:56 pmBUSForm 8.3 - Georgia Capital Plc
26th Jun 20201:25 pmRNSUpdate on General Meeting
26th Jun 202011:18 amRNSForm 8 (DD) - [Georgia Capital PLC]
25th Jun 20205:44 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.